Nyxoah S.A. (NYXH)
10.34
-0.14 (-1.34%)
At close: Feb 20, 2025, 2:45 PM
10.40
0.58%
After-hours: Feb 20, 2025, 02:45 PM EST
undefined% (undefined)
| Bid | 10.3 |
| Market Cap | 355.56M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.81 |
| PE Ratio (ttm) | -5.71 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 12.49 |
| Volume | 8,671 |
| Avg. Volume (20D) | 46,686 |
| Open | 10.40 |
| Previous Close | 10.48 |
| Day's Range | 10.30 - 10.34 |
| 52-Week Range | 6.76 - 20.00 |
| Beta | undefined |
About NYXH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium....
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 28, 2021
Employees 146
Stock Exchange NASDAQ
Ticker Symbol NYXH
Website https://www.nyxoah.com
Analyst Forecast
According to 5 analyst ratings, the average rating for NYXH stock is "Buy." The 12-month stock price forecast is $17, which is an increase of 64.41% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Nyxoah S.A. is scheduled to release its earnings on Mar 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+1.52%
Nyxoah shares are trading higher after the company...
Unlock content with
Pro Subscription
9 months ago
-17.69%
Nyxoah shares are trading lower after the company announced the pricing of a $50 million public offering of 5,374,755 shares at $9.25 per share.
